With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
In January 2018, a class-action lawsuit was filed against Enzymatic Therapy for allegedly deceptively advertising that Ultra Liver Cleanse is able to “Remove Toxins” and cleanse and rejuvenate the liver when, according to plaintiffs, the product cannot detoxify, cleanse, or rejuvenate the liver. Plaintiffs also claim that the company misleads consumers by communicating that the product has “drug-like effects” when it is not an FDA approved drug. (Jocelyn et al v. Enzymatic Therapy, LLC, Case No. 18-cv-564, E.D.N.Y.)
TINA.org and other consumer advocates file comment with FTC.
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Marketing and reality are not in sync.
New study opens the floodgates to class-action litigation.
Agency alleges MLM misled recruits about earnings, pressured distributors to buy products and encouraged fake retail sales.